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Abstract	
	
Although	basal	cells	are	known	to	function	as	human	airway	epithelial	stem	cells,	analysis	of	
these	cells	has	been	limited	by	in	vitro	culture	techniques	that	only	permit	minimal	cell	
growth	and	differentiation.	Here,	we	report	a	protocol	that	dramatically	increases	the	long-
term	expansion	of	primary	human	airway	basal	cells	while	maintaining	their	genomic	
stability	using	3T3-J2	fibroblast	co-culture	and	ROCK	inhibition	using	Y-27632.	We	also	
describe	techniques	for	the	differentiation	and	immunofluorescence	imaging	of	these	
expanded	airway	stem	cells	as	three-dimensional	tracheospheres	containing	basal,	ciliated	
and	mucosecretory	cells.	This	3D	procedure	allows	investigation	of	the	proximal	airway	
epithelium	under	more	physiologically	relevant	conditions	than	those	found	in	traditional	
monolayer	cultures.	Together	these	methods	represent	a	novel	platform	for	improved	
airway	stem	cell	growth	and	differentiation	that	is	compatible	with	high	throughput,	high	
content	translational	lung	research	as	well	as	human	airway	tissue	engineering	and	clinical	
cellular	therapy.	
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1.	Introduction	
	
Human	airways	represent	a	key	environmental	barrier	whose	dysregulation	in	diseases	such	
as	asthma,	COPD,	cystic	fibrosis	and	cancer	is	a	major	cause	of	worldwide	morbidity	and	
mortality	(1).	Human	airways	are	composed	of	a	pseudostratified	ciliated	and	mucosecretory	
epithelium	responsible	for	protecting	against	inhaled	particulate	matter,	pathogens,	and	
other	airborne	toxicants.		Supporting	this	epithelium	are	multipotent	basal	stem	cells	
characterized	primarily	by	cytokeratin	5	(CK5)	and	P63	expression	(2,	3).		Given	the	clear	
physiological	importance	of	maintaining	human	airway	homeostasis,	establishing	techniques	
for	investigating	basal	stem	cell	growth	and	differentiation	is	of	significant	basic	and	
translational	relevance	(4).	
	
Historically,	the	majority	of	airway	stem	cell	research	has	involved	studies	of	animal	models	
that	exhibit	only	limited	human	translational	relevance	(1).		To	overcome	this,	researchers	
have	traditionally	used	human	air-liquid	interface	(ALI)	cultures	in	which	a	confluent	
monolayer	of	human	airway	basal	cells	is	cultured	in	medium	containing	retinoic	acid	and	
grown	at	an	air	interface	to	encourage	ciliated	and	mucosecretory	cell	differentiation	(5,	6).		
Despite	the	human	biological	relevance	of	these	ALI	models	(7),	they	remain	extremely	time-
consuming	and	poorly	suited	to	high	throughput,	high	content	translational	medicine	
approaches.	In	addition,	evidence	suggests	that	airway	basal	stem	cells	rapidly	lose	their	
capacity	for	multipotent	differentiation	and	undergo	premature	senescence	after	only	a	
small	number	of	passages.	This	failure	to	maintain	airway	epithelial	stem	cells	in	vitro	
presents	a	considerable	barrier	for	their	use	in	translational	medicine.	
	
In	this	chapter,	we	describe	a	protocol	for	improved	human	airway	stem	cell	expansion	that	
maintains	their	multipotent	differentiation	capacity.	Originally	developed	for	epidermal	
keratinocyte	stem	cells,	this	technique	relies	upon	the	co-culture	of	primary	human	
epithelial	cells	with	mitotically	inactivated	3T3-J2	fibroblast	feeder	cells	(8).		Epithelial	and	J2	
feeder	cell	co-cultures	are	grown	in	medium	containing	the	Rho-associated	kinase	(ROCK)	
inhibitor	Y-27632	(9-11).	Successful	application	of	this	procedure	to	airway	epithelial	cells	
provides	large	numbers	of	basal	cells	that	exhibit	physiologically	relevant	differentiation,	
karyotype	stability	and	maintenance	of	telomere	length	(12).		In	addition,	we	also	provide	
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methods	for	the	differentiation	and	visualization	of	human	airway	basal	cells	as	3D	airway	
tracheospheres.	These	techniques	build	on	previous	3D	culture	systems	in	which	either	
ciliated	or	mucosecretory	differentiation	was	achieved	(2,	13,	14).	The	method	described	
here,	based	on	several	recently	published	studies,	permits	normal	ciliated	and	
mucosecretory	cell	differentiation	(12,	15,	16)	and	is	compatible	with	high-throughput,	high-
content	analyses.	Together	these	methods	provide	a	platform	to	expand	large	numbers	of	
airway	basal	epithelial	cells	from	patient	endobronchial	biopsy	samples	and	differentiate	
them	in	a	3D	tracheosphere	assay	with	potential	applications	in	translational	medicine,	
tissue	engineering	and	cellular	therapy	approaches.	
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2.	Materials		
	
2.1.	Human	Airway	Epithelial	Cell	Isolation	
1. RPMI	medium	with	L-glutamine	(Gibco,	Thermo	Fisher).	Storage	at	4°C.	
2. Dispase	(Corning).	Storage	at	-20°C.	
3. 0.25%	Trypsin-EDTA	(Gibco,	Thermo	Fisher).	Storage	at	-20°C.	
4. Neutralization	medium:	Dulbecco’s	modified	Eagle’s	medium	(DMEM)	with	4.5g/L	D-
glucose,	L-glutamine	and	pyruvate	(Gibco,	Thermo	Fisher)	plus	10%	fetal	bovine	
serum	(FBS)	and	1X	Penicillin/Streptomycin	(Gibco,	Thermo	Fisher).	Storage	at	4°C.	
5. Transport	medium:	αMEM	(Gibco,	Thermo	Fisher)	plus	1X	Penicillin/Streptomycin	
(Gibco,	Thermo	Fisher),	1X	Gentamicin	(Gibco,	Thermo	Fisher)	and	1X	Amphotericin	B	
(Fisher	Scientific).	Storage	at	4°C.	
	
2.2.	3T3-J2	Feeder	Cell	Culture	
1. Dulbecco’s	modified	Eagle’s	medium	(DMEM)	with	4.5g/L	D-glucose,	L-glutamine	and	
pyruvate	(Gibco,	Thermo	Fisher).	Storage	at	4°C.	
2. Bovine	serum	(Gibco,	Thermo	Fisher).	Storage	at	-80°C.	
3. Penicillin/Streptomycin	(Gibco,	Thermo	Fisher).	Storage	at	-20°C.	
4. Mitomycin	C	(Sigma-Aldrich):	0.4	mg/ml	in	sterile	PBS.	Storage	at	-20°C.	
5. 0.05%	Trypsin-EDTA	(Gibco,	Thermo	Fisher).	Storage	at	-20°C,	4°C	short-term.	
6. Complete	fibroblast	culture	medium:	500	ml	DMEM	plus	45	ml	bovine	serum	and	1X	
Penicillin/Streptomycin.	Storage	at	4°C.	
	
2.3.	Human	Airway	Epithelial	Cell	Culture	
1. Phosphate-buffered	saline	(PBS;	Sigma).	
2. Dulbecco’s	modified	Eagle’s	medium	(DMEM)	with	4.5g/L	D-glucose,	L-glutamine	and	
pyruvate	(Gibco,	Thermo	Fisher).	Storage	at	4°C.	
3. Fetal	bovine	serum	(FBS;	Gibco,	Thermo	Fisher;	see	Note	1).	Storage	at	-80°C	long-
term,	-20°C	until	use.	
4. Penicillin/Streptomycin	(Gibco,	Thermo	Fisher).	Storage	at	-20°C.	
5. Ham’s	F-12	nutrient	mixture	with	L-glutamine	(Gibco,	Thermo	Fisher).	Storage	at	4°C.	
6. Gentamicin	(Gibco,	Thermo	Fisher):	100X.	Storage	at	4°C.	
6		
7. Amphotericin	B	(Fisher	Scientific):	250	μg/ml,	1000X.	Storage	at	-20°C.	
8. Hydrocortisone	(Sigma-Aldrich).	See	Note	2	for	storage	conditions.	
9. Recombinant	human	EGF	(Thermo	Fisher).	See	Note	2	for	storage	conditions.	
10. Insulin,	1,000X	stock	(Sigma-Aldrich):	5	mg/ml	in	distilled	water	(add	glacial	acetic	
acid	dropwise	to	dissolve	and	sterile	filter).	Storage	at	-20°C.	
11. Cholera	Toxin	(Sigma-Aldrich):	1	mg/ml	(11.7	μM)	in	distilled	water.	Storage	at	4°C.	
12. Y-27632	(Cambridge	Bioscience):	5	mM	in	distilled	water.	Storage	at	-20°C.	
13. Complete	epithelial	culture	medium:	373	ml	serum-containing	DMEM	(500	ml	DMEM	
plus	50	ml	FBS	and	1X	Penicillin/Streptomycin),	125	ml	Ham’s	F-12,	0.5	ml	
gentamicin,	0.5	ml	Amphotericin	B,	0.5	ml	hydrocortisone/EGF	(see	Note	2),	0.5	ml	
insulin,	0.5	ml	Y-27632,	4.3	μl	cholera	toxin.	Storage	at	4°C	for	up	to	2	weeks.	
14. Profreeze	Chemically	Defined	Freezing	Medium	(2X;	Lonza).	
	
2.4.	3D	Human	Tracheospheres	
1. Matrigel,	basement	membrane	matrix,	growth	factor	reduced	(BD	Biosciences;	see	
Note	3).	Storage	at	-20°C.	
2. Ultra-low	attachment	96-well	plate	(Corning).	
3. Bronchial	epithelial	growth	medium	with	supplements	(BEGM;	Lonza).	Medium	
stored	at	4°C,	supplements	at	-20°C.	
4. Dulbecco’s	modified	Eagle’s	medium	(DMEM)	with	4.5g/L	D-glucose,	L-glutamine	and	
pyruvate	(Gibco,	Thermo	Fisher).	Storage	at	4°C.	
5. Y-27632	(Cambridge	Bioscience):	5	mM	in	distilled	water.	Storage	at	-20°C.	
6. All-trans	retinoic	acid	(Sigma):	10	mM		in	100%	EtOH	(50	mg	in	16.642	ml).	Storage	at	
-80°C	(see	Note	4).	
7. Tracheosphere	medium:	50%	DMEM	(no	serum,	no	antibiotics),	50%	bronchial	
epithelial	basal	medium	(plus	all	of	the	BEGM	supplements	except	amphotericin	B,	
triiodothyronine	and	retinoic	acid).	Storage	at	4°C.	Supplemented	with	5	μM	Y-27632	
for	cell	seeding	(but	not	subsequent	feeds).	Always	supplemented	with	100	nM	all-
trans	retinoic	acid	at	the	time	of	use.	
	
2.5.	Immunofluorescence	Staining	of	Tracheospheres	
1. 4%	(w/v)	paraformaldehyde	in	PBS.	Heat	to	65°C	to	dissolve	and	adjust	pH	to	7.2.	
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2. HistoGel	Specimen	Processing	Gel	(Thermo	Scientific;	see	Note	5).	
3. Blocking	solution	(10%	FBS	in	PBS).	
4. DAPI	(4’,6-diamidino-2-phenylindole;	Molecular	Probes).	Stock	solution:	10	μg/ml.	
5. Mounting	medium	(Immu-mount,	Thermo	Scientific).	
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3.	Methods	
	
3.1.	Preparation	of	3T3-J2	Feeder	Layers	
1. Maintain	3T3-J2	cells	at	low	passage	numbers	(see	Note	6)	and	maintain	them	
subconfluent	(see	Note	7)	in	37°C,	5%	CO2	incubators	with	weekly	splits	of	1:8-1:10.	
2. For	feeder	layer	preparation,	add	mitomycin	C	(4	μg/ml;	final	concentration)	to	flasks	
of	3T3-J2	cells	in	fibroblast	culture	medium	for	2	hours	(see	Note	8).	
3. Wash	cells	with	PBS,	harvest	cells	with	0.05%	trypsin-EDTA	and	replate	at	a	density	of	
at	least	20,000	feeder	cells/cm2	in	fibroblast	culture	medium	(see	Note	9).	
4. Allow	3T3-J2	cells	to	adhere	and	spread	overnight	before	adding	epithelial	cells	the	
following	day	(see	Note	10).	
	
3.2.	Isolation	of	Human	Airway	Epithelial	Cells	
1. Derivation	of	human	cells	should	be	approved	by	the	relevant	local	ethics	committee.	
2. Human	airway	epithelial	cells	are	derived	from	brushings	or	biopsies	taken	during	
bronchoscopy	procedures.	Samples	are	transported	to	the	laboratory	on	ice	as	soon	
as	possible.	
	
3.2.1.	Cell	seeding	from	brushings	
1. Brushes	are	collected	in	15	ml	falcon	tubes	in	transport	medium.	
2. Thoroughly	vortex	tubes	to	remove	cells	from	the	brush.	
3. Centrifuge	tubes,	with	brushes	inside,	at	300	xg	for	5	minutes.	
4. Carefully	remove	transport	medium	and	resuspend	the	cell	pellet	in	
epithelial	culture	medium	(see	Note	11).	
5. Seed	cell	suspension	on	pre-prepared	T25	feeder	layers,	incubate	at	37°C	
(5%	CO2)	and	change	the	medium	after	two	days.		
6. Epithelial	colonies	become	evident	after	2-3	days	(see	Note	12).	
	
3.2.2.	Cell	seeding	from	biopsies	
1. For	explant	cultures,	biopsies	are	seeded	directly	onto	pre-prepared	
feeder	layers	with	a	minimal	covering	of	epithelial	culture	medium	(Figure	
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1A;	see	Note	13)	or	they	can	be	digested	to	form	a	cell	suspension	prior	to	
culture.	
2. To	digest	a	biopsy,	carefully	transfer	the	biopsy	to	an	eppendorf	tube	
containing	16	U/ml	dispase	in	RPMI.	Digest	for	20	minutes	at	room	
temperature.		
3. Neutralize	the	digestion	by	adding	an	equal	volume	of	neutralization	
medium.	
4. Transfer	the	tissue	to	a	sterile	petri	dish	and	dissect	away	epithelium	(see	
Note	14).	
5. Transfer	to	an	eppendorf	containing	0.1%	trypsin-EDTA	(diluted	in	RPMI)	
and	incubate	at	37°C	for	30	minutes.	Remove	cells	from	the	incubator	and	
agitate	by	pipetting	every	10	minutes.	
6. Neutralize	the	trypsin	by	addition	of	at	least	the	same	volume	of	
neutralization	medium	and	pipette	thoroughly.	
7. Combine	the	neutralized	digest	with	the	neutralized	dispase	solution	from	
Step	3.	
8. Centrifuge	cells	at	300	xg	for	5	minutes.	
9. Remove	supernatant	and	resuspend	the	pellet	in	epithelial	culture	
medium.	
10. Seed	cell	suspension	on	pre-prepared	T25	feeder	layers,	incubate	at	37°C	
(5%	CO2)	and	change	the	medium	after	two	days.	
11. Epithelial	colonies	become	evident	after	2-3	days.	
	
3.3.	Maintenance	of	Human	Airway	Basal	Epithelial	Cells	
1. During	normal	maintenance	epithelial	cells	are	fed	with	fresh	complete	epithelial	
medium	three	times	per	week	(10	ml	per	T75	or	equivalent	for	other	vessel	surface	
areas)	and	stored	in	37°C,	5%	CO2	incubators.	
2. Passage	epithelial	cell	cultures	at	80-90%	confluence	(Figure	1B).	
3. Remove	epithelial	culture	medium	and	wash	cells	once	with	PBS.	
4. Add	0.05%	trypsin-EDTA	(see	Note	15)	for	2	minutes	at	room	temperature,	gently	tap	
flasks	and	confirm	the	removal	of	feeder	cells,	which	are	substantially	more	trypsin-
sensitive	than	epithelial	cells,	under	a	microscope.	
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5. Remove	the	trypsin	and	wash	with	PBS	to	remove	remaining	feeder	cells.	
6. Add	0.05%	trypsin-EDTA	and	incubate	at	37°C	until	epithelial	cells	detach	from	the	
flask	(typically	this	takes	5	minutes;	see	Note	16).	
7. Neutralize	the	trypsin	solution	with	the	same	volume	of	epithelial	culture	medium,	
centrifuge	at	300	xg	for	5	minutes	and	resuspend	the	pellet	in	epithelial	culture	
medium.	
8. For	continued	passage,	perform	a	1:5	split	and	seed	cells	onto	a	pre-prepared	feeder	
layer	in	complete	epithelial	culture	medium.	Incubate	in	a	37°C,	5%	CO2	incubator.	
9. To	cryopreserve,	freeze	0.5	x	106	cells/vial	in	200	μl	total	volume	using	Profreeze	
freezing	medium	according	to	the	manufacturer’s	instructions.	
	 	
3.4.	3D	Tracheosphere	Culture	
1. Coat	the	base	of	a	non-adherent	96-well	plate	with	25%	pre-chilled	Matrigel	in	
tracheosphere	medium	(30	μl	per	well)	and	transfer	to	an	incubator	(37°C,	5%	CO2)	
for	at	least	20	minutes	(see	Note	17).	
2. Differentially	trypsinize	cultured	airway	basal	cells	from	feeder	cells	as	described	
above	(Step	3.3.3).	For	one	96-well	plate,	resuspend	270,000	basal	cells	in	7	ml	
tracheosphere	medium	containing	5%	pre-chilled	Matrigel	and	5	μM	Y-27632.	Add	65	
μl	cell	suspension	per	well	(2,500	cells	per	well,	see	Note	18).	Return	the	plate	to	an	
incubator	(37°C,	5%	CO2;	see	Note	19).	
3. Feed	cells	by	adding	70	μl	tracheosphere	medium	(without	Y-27632)	on	days	3,	8	and	
14	of	culture	(Figure	2A).	
4. On	day	18	of	culture	tracheospheres	are	well	differentiated	with	basal	cells,	goblet	
cells	and	ciliated	cells	present	(Fig.	1;	see	Note	20).		
	
3.5.	Immunofluorescence	Staining	of	Tracheospheres	
1. To	collect	tracheospheres,	pipette	the	well	contents	into	chilled	PBS	on	ice	using	200	
μl	pipette	tips	with	the	ends	cut	off.	Centrifuge	at	200	xg	for	3	minutes.	Fix	
tracheospheres	by	resuspension	in	4%	PFA	for	30	minutes.			
2. Using	the	same	centrifuge	settings,	wash	once	with	PBS	and	resuspend	the	
tracheosphere	pellet	in	pre-warmed	HistoGel	specimen	processing	gel.	Pipette	the	
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HistoGel	onto	parafilm	as	small	droplets	appropriate	for	embedding	and	allow	it	to	
gel	at	room	temperature	for	10	minutes.	
3. Process,	embed	and	stain	the	tracheospheres	according	to	standard	histology	
protocols	(Figure	2B-D).	
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4.	Notes	
	
1) Batch	testing	of	FBS	for	the	ability	to	support	rapid	expansion	and	serial	passage	of	
primary	human	epithelial	cells	is	essential.	
2) Hydrocortisone/EGF	stock	is	prepared	by	dissolving	hydrocortisone	at	0.5	mg/ml	in	
100%	ethanol.	1	ml	hydrocortisone	is	added	to	19	ml	DMEM	containing	2.5	μg	
recombinant	human	EGF.	Hydrocortisone/EGF	stock	aliquots	are	stored	at	-20°C.	
3) A	bottle	of	Matrigel	must	be	thawed	on	ice	for	>6	hours.	Once	thawed,	Matrigel	
should	be	aliquoted	into	pre-chilled,	sterile	eppendorf	tubes	and	stored	at	-20°C.	
Freeze-thaw	Matrigel	a	maximum	of	three	times.	Matrigel	should	be	kept	on	ice	
throughout	the	tracheosphere	seeding	process.	
4) Retinoic	acid	is	extremely	light	sensitive.	Care	should	be	taken	to	minimize	light	
exposure	during	preparation	and	storage,	for	example	by	foil	wrapping	falcon	tubes.	
Aliquotted	10	mM	stocks	can	be	stored	for	up	to	one	month	at	-80°C.	We	prepare	a	
1:1000	(10	μM)	stock	and	dilute	this	1:100	to	prepare	tracheosphere	medium	(final	
conc.	100	nM).	
5) A	10	ml	vial	of	HistoGel	should	be	pre-heated	to	65°C	in	a	waterbath	for	30	minutes.	
HistoGel	can	be	aliquoted	into	1.5	ml	eppendorf	tubes	to	reduce	this	time	to	10	
minutes	and	sets	quickly	at	room	temperature	so	should	be	kept	at	65°C	until	use.	
6) We	thaw	fresh	3T3-J2	cells	after	passage	12	as	the	cells	are	susceptible	to	undergoing	
spontaneous	transformation,	proliferating	more	rapidly	and	adopting	a	cuboidal	
morphology	compared	with	the	usual	spread	appearance	of	fibroblasts.	
7) 3T3-J2	cultures	should	never	be	allowed	to	become	over	confluent	as	their	
morphology	and	sensitivity	to	irradiation/mitomycin	C	can	be	affected,	leading	to	
poor	quality	feeder	layers.	
8) Alternatively,	3T3-J2s	can	be	mitotically	inactivated	by	40	Gy	(4000	rd)	irradiation.	
9) After	mitotic	inactivation,	3T3-J2	cells	are	fragile	and	care	should	be	taken	when	
pipetting	the	cells	as	excessive	stress	can	cause	feeder	layers	to	degenerate	more	
rapidly.	
10) Co-seeding	of	3T3-J2	and	epithelial	cells	in	complete	epithelial	culture	medium	
produces	poor	quality	feeder	layers.	Mitotically	inactivated	fibroblasts	do	not	spread,	
as	when	seeded	in	fibroblast	culture	medium,	and	feeder	layers	degenerate	more	
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quickly.	Thus,	it	is	important	to	be	well-organized	in	the	planning	of	experiments	
using	co-cultured	cells.	
11) Care	should	be	taken	to	wash	the	brush	with	epithelial	culture	medium	to	free	as	
many	cells	as	possible.	We	use	at	least	two	rounds	of	washing	with	fresh	medium.	
12) Contamination	of	cultures	with	human	fibroblasts	has	not	been	a	problem	in	our	lab.	
It	is	thought	that	the	combination	of	the	feeder	layers	and	culture	medium	additives	
suppress	the	growth	of	fibroblasts.	
13) We	do	not	change	the	medium	on	explant	biopsies	for	the	first	7	days	of	culture	in	
order	to	avoid	the	risk	of	detaching	the	biopsy	by	moving	the	flask.	Epithelial	
outgrowths	are	normally	visible	in	the	second	week	and	can	be	serially	passaged	as	
described	in	Step	3.3.3.	
14) In	practice,	it	is	difficult	to	see	the	epithelium	at	this	stage	-	after	proper	dispase	
digest	the	biopsy	will	appear	‘fluffy’	-	but	we	do	find	that	pulling	apart	the	biopsy	at	
this	stage	improves	the	efficiency	of	the	trypsin	step.	
15) TrypLE	Select	(Gibco,	Thermo	Fisher),	a	recombinant	trypsin	that	avoids	the	use	of	
porcine	trypsin	in	human	cultures,	can	be	used	in	place	of	0.05%	Trysin-EDTA	for	
passaging	epithelial	cells	with	no	negative	impact	on	the	quality	of	cultures.	
16) Epithelial	cells	should	be	treated	with	care	during	passaging.	We	remove	cells	
following	trypsinization	by	gently	tapping	flasks	rather	than	by	washing.	Care	should	
also	be	taken	to	avoid	excessive	pipetting	of	epithelial	cells	during	resuspension.	
17) To	maximize	the	well	volume	available	for	addition	of	culture	medium,	the	Matrigel	
layer	at	the	well	base	is	minimal.	Non-adherent	culture	plates	are	used	to	prevent	
cells	in	close	proximity	to	the	culture	plastic	from	losing	3D	structure.	
18) Video	microscopy	studies	indicate	that	tracheospheres	formed	from	cells	at	this	
density	are	not	clonal	but	multiple	basal	cells	in	the	initial	culture	can	migrate	and	
interact	to	form	tracheospheres.	
19) Tracheospheres	are	very	sensitive	to	culture	conditions.	We	use	dedicated	
incubators,	with	extra	humidification,	for	airway	differentiation	assays	in	order	to	
reduce	the	number	of	times	incubator	doors	are	opened	and	to	better	maintain	
constant	humidity,	CO2,	etc.		
20) The	abundance	of	cilia	in	tracheospheres	increases	over	time.	Cilia	are	observed	at	
day	14	but	longer	culture	periods	produce	better	results.	This	must	be	balanced	with	
14		
the	ability	to	continue	to	add	culture	medium	to	wells.	End-point	assays	can	be	
performed	between	day	14	and	day	21.	
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Figure	1:	(A)	Phase-contrast	image	of	epithelial	cell	outgrowth	from	an	endobronchial	biopsy	
grown	on	a	3T3-J2	feeder	layer	in	medium	containing	the	ROCK	inhibitor	Y-27632	(3T3+Y).	
(B)	Phase-contrast	image	of	colonies	of	sub-cultured	human	airway	epithelial	cells	grown	in	
3T3+Y.	
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Figure	2:	(A)	Schematic	representation	of	airway	tracheosphere	formation	in	3D	Matrigel	
culture	with	brightfield	images	showing	the	time	course	of	tracheosphere	growth.	(B)	
Haematoxylin	and	eosin	(H&E)	staining	of	a	tracheosphere.	Scale	bar	=	50	μm.	(C)	Whole-
mount	immunofluorescence	staining	of	tracheospheres	at	day	7	and	day	14	shows	that	BrdU	
uptake	is	high	in	the	early	stages	of	culture,	as	tracheospheres	form,	but	reduces	over	time.	
Scale	bar	=	100	μm.	(D)	Immunofluorescence	staining	of	tracheospheres	shows	the	
differentiation	of	cultured	primary	human	airway	basal	cells	into	both	ciliated	(ACT;	green)	
and	mucosecretory	(MUC5B;	red)	cells	in	tracheospheres.	Scale	bar	=	20	μm.	
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